StockData
Xencor Inc logo

Xencor Inc (XNCR) stock

XNCRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 5/30191% above fair value
$34.01−0.38 (-1.10%)

Close on Nov 19, 2026Market cap $2.53BP/E –Yield –

Xencor operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Xencor's operating income for the twelve months ending Jun 30, 2026 was -$216.08M. For fiscal 2025 it was -$177.50M. The highest annual figure on record is $44.04M in fiscal 2016.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$177.50M–
FY2024Dec 31, 2024-$178.41M–
FY2023Dec 31, 2023-$132.36M–
FY2022Dec 31, 2022-$82.47M-288.4%
FY2021Dec 31, 2021$43.77M–
FY2020Dec 31, 2020-$76.80M-655.5%
FY2019Dec 31, 2019$13.82M–
FY2018Dec 31, 2018-$79.37M–
FY2017Dec 31, 2017-$43.12M-197.9%
FY2016Dec 31, 2016$44.04M–
FY2015Dec 31, 2015-$18.34M–
FY2014Dec 31, 2014-$16.46M–
FY2013Dec 31, 2013-$10.52M–
FY2012Dec 31, 2012-$6.23M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$37.07M–
Q1 FY2026Mar 31, 2026-$77.86M–
Q4 FY2025Dec 31, 2025-$53.63M–
Q3 FY2025Sep 30, 2025-$47.52M–
Q2 FY2025Jun 30, 2025-$33.17M–
Q1 FY2025Mar 31, 2025-$43.18M–
Q4 FY2024Dec 31, 2024-$13.18M–
Q3 FY2024Sep 30, 2024-$55.20M–
Q2 FY2024Jun 30, 2024-$55.37M–
Q1 FY2024Mar 31, 2024-$54.66M–
Q4 FY2023Dec 31, 2023-$27.35M–
Q3 FY2023Sep 30, 2023-$18.27M–
Q2 FY2023Jun 30, 2023-$26.00M–
Q1 FY2023Mar 31, 2023-$60.74M-329.5%
Q4 FY2022Dec 31, 2022-$42.59M-146.5%
Q3 FY2022Sep 30, 2022-$38.35M–
Q2 FY2022Jun 30, 2022-$28.00M-408.1%
Q1 FY2022Mar 31, 2022$26.47M–
Q4 FY2021Dec 31, 2021$91.65M–
Q3 FY2021Sep 30, 2021-$41.30M–
Q2 FY2021Jun 30, 2021$9.09M–
Q1 FY2021Mar 31, 2021-$15.67M–
Q4 FY2020Dec 31, 2020-$13.70M–
Q3 FY2020Sep 30, 2020-$16.72M–
Q2 FY2020Jun 30, 2020-$37.60M–
Q1 FY2020Mar 31, 2020-$8.78M-111.2%
Q4 FY2019Dec 31, 2019-$30.57M–
Q3 FY2019Sep 30, 2019-$14.28M-2292.9%
Q2 FY2019Jun 30, 2019-$19.57M–
Q1 FY2019Mar 31, 2019$78.24M–
Q4 FY2018Dec 31, 2018-$21.08M-495.8%
Q3 FY2018Sep 30, 2018$651.00K–
Q2 FY2018Jun 30, 2018-$28.29M–
Q1 FY2018Mar 31, 2018-$30.65M–
Q4 FY2017Dec 31, 2017$5.33M–
Q3 FY2017Sep 30, 2017-$23.58M–
Q2 FY2017Jun 30, 2017-$8.51M–
Q1 FY2017Mar 31, 2017-$16.36M–
Q4 FY2016Dec 31, 2016-$10.03M–
Q3 FY2016Sep 30, 2016-$9.26M–

More Xencor figures

See a number that looks wrong?